• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries
    Business Exposures
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    OS Therapies Appoints Kerry Clem as Chief Commercial Officer and Frank Knuettel II as Chief Financial Officer
    Via Newsfile
    Tickers OSTX
    Exposures Product Safety
    News headline image
    PharmaTher Enters into Exclusive North American Distribution Agreement with Craft Health for CraftMake(TM) Pharmaceutical 3D Printing Platform
    Via Newsfile
    Tickers CSE:PHRM PHRRF
    Exposures Product Safety
    News headline image
    $11 Million Dollar Award for Robotic Magnetic Stimulation with Pharma Treatment for Resistant Depression Greatly Expands Application Potential for NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)
    Via Get News
    Topics Intellectual Property
    Tickers NRXP
    Exposures Intellectual Property Product Safety
    News headline image
    Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea — General Debate under Item 3, 63rd session of the Human Rights Council
    Via 24-7 Press Release
    Topics Product Recall Religion
    Exposures Legal Product Safety Religion
    News headline image
    Pre-trial Detention of Chairman Lee Man-hee Brought Before UN Human Rights Council
    Via 24-7 Press Release
    Topics Product Recall Religion
    Exposures Legal Product Safety Religion
    News headline image
    Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors With Significant Losses to Contact the Firm Before November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    Tickers BBNX
    Exposures Financial Legal Product Safety
    News headline image
    $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
    Via PRLog
    Exposures Product Safety
    News headline image
    3 Reasons to Buy Grail (GRAL) Hand Over Fist in October ↗
    Via The Motley Fool
    Tickers GRAL ILMN
    Exposures Product Safety
    News headline image
    3 Healthcare Dividend Stocks Offering More Than Just Income ↗
    Via MarketBeat
    Tickers ABBV JNJ MRK
    Exposures Product Safety
    News headline image
    Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is November 2, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit
    Tickers UNCY
    Exposures Financial Legal Product Safety
    News headline image
    Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run. ↗
    Via The Motley Fool
    Tickers GRAL
    Exposures Product Safety
    News headline image
    Why Grail Stock Skyrocketed Nearly 70% In A Week. What To Watch Next. ↗
    Via Investor's Business Daily
    Exposures Product Safety
    News headline image
    Naugatuck, CT Author Explores Identity, Representation, and Black Experience
    Via PR Leap
    Topics Product Recall
    Exposures Legal Product Safety
    News headline image
    Kaplan Fox Alerts Investors to an Upcoming Deadline of November 3, 2026 in the Beta Bionics, Inc. (NASDAQ: BBNX) Securities Class Action
    Via NewMediaWire
    Topics Lawsuit
    Tickers BBNX
    Exposures Financial Legal Product Safety
    News headline image
    Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors Encouraged to Contact the Firm
    Via NewMediaWire
    Tickers BAC MDLN
    Exposures Product Safety
    News headline image
    Kaplan Fox Encourages Investors of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Who Suffered Losses to Contact the Firm
    Via NewMediaWire
    Tickers FULC
    Exposures Product Safety
    News headline image
    Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate
    Via B2i Digital
    Tickers UNCY
    Exposures Product Safety
    News headline image
    Neogen (NEOG) Stock Trades Down, Here Is Why
    Via StockStory
    Topics Death
    Tickers NEOG PLTR
    Exposures Death Product Safety
    News headline image
    Aldeyra to Appeal FDA Rejection of Reproxalap for Dry Eye Disease ↗
    Via MarketBeat
    Tickers ALDX
    Exposures Product Safety
    News headline image
    Inventiva (IVA) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Tickers IVA
    Exposures Financial Product Safety
    News headline image
    Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Seek Leadership in a Securities Fraud Lawsuit by November 3, 2026
    Via NewMediaWire
    Topics Fraud Lawsuit
    Tickers BBNX
    Exposures Financial Legal Product Safety
    News headline image
    ReposiTrak (TRAK) Q4 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Product Recall
    Tickers TRAK
    Exposures Financial Legal Product Safety
    News headline image
    VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs
    Via AB Newswire
    Tickers ARAY FUSE GYGY IGC KNRX LLY
    Exposures Product Safety
    News headline image
    Kaplan Fox & Kilsheimer LLP Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors to the Lead Plaintiff Deadline on November 3, 2026
    Via NewMediaWire
    Topics Lawsuit
    Tickers BBNX
    Exposures Financial Legal Product Safety
    News headline image
    ReposiTrak Q4 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Tickers TRAK
    Exposures Financial Product Safety
    News headline image
    RIXA Recovery and Performance Announces Grand Opening of New Perrysburg Location
    Via Press Advantage
    Exposures Product Safety
    News headline image
    Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1
    Via Newsfile
    Topics Lawsuit
    Tickers REPL
    Exposures Financial Legal Product Safety
    News headline image
    DreaMed Receives FDA Clearance for MODI, Bringing Automated Insulin Dose Recommendations to People with Type 2 Diabetes Using Injections
    Via Newsfile
    Exposures Product Safety
    News headline image
    Kaplan Fox Deadline Alert: Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors Have Until November 2, 2026 to Seek a Lead Plaintiff Role
    Via NewMediaWire
    Topics Lawsuit
    Tickers UNCY
    Exposures Financial Legal Product Safety
    News headline image
    Xenon Files Azetukalner NDA as It Pauses Psychiatry Trials for Tolerability Review ↗
    Via MarketBeat
    Tickers XENE
    Exposures Product Safety
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.